Skip to main content

Table 1 The basic demographic characteristics of the patients and the cycle of ovarian stimulation

From: GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

 

Agonist group

Antagonist group

P

Patients (n)

32

32

 

Age (years)

33.2 ± 3.0

32.5 ± 3.0

0.39

BMI (kg/m2)

23.5 ± 3.2

23.2 ± 3.0

0.48

Duration of infertility (years)

4.4 ± 3.0

4.1 ± 3.0

0.33

Infertility

  

0.11

Primary

56.2% (18/32)

78.1% (25/32)

 

Secondary

43.8% (14/32)

21.9% (7/32)

 

Tobacco use (%)

3.1% (1/32)

0 (0/32)

0.31

Regular alcohol use

12.5% (4/32)

3.1% (1/32)

0.35

Etiology

  

0.59

Male factor

50% (16/32)

53.1% (17/32)

 

Idiopathic

34.4% (11/32)

21.9% (7/32)

 

Tubal factor

9.3% (3/32)

18.7% (6/32)

 

Male + Tuboperitoneal

6.3% (2/32)

6.3% (2/32)

 

Total dose FSH (UI)

2185.5 ± 617

1877.3 ± 817

0.09

Total dose LH (UI)

1094.5 ± 258

1026.5 ± 385

0.87

Time of stimulation (days)

11 ± 1.8

10.4 ± 3.2

0.82

Follicles (n) (hCG day)

   

Total (≥10 mm)

≥16 mm

15.9 ± 8.3

6.9 ± 3.1

17.7 ± 9.2

7.5 ± 3.6

0.49

0.47

≥18 mm

4.1 ± 2.1

4.1 ± 1.8

0.65

Retrieved oocytes:

   

Total

12.5 ± 6.9

13.4 ± 7.0

0.57

Metaphase II stage

9.3 ± 5.9

9.8 ± 6.0

0.77

Metaphase I stage

1.3 ± 1.5

1.4 ± 1.4

0.22

Germinal vesicle stage

1.3 ± 2.5

0.9 ± 1.4

0.88

Implantation rate

29% (18/62)

27.4% (17/62)

1.00

Pregnancy rate

40.6% (13/32)

37.5% (12/32)

0.79